News | August 05, 2021
IPCA Labs reports Q1FY22 net at Rs 306.66 Cr
Total income grew in the quarter
Total income grew in the quarter
It is part of the company’s pain/analgesics portfolio of OTC products
Aditya Puri former MD of HDFC bank joins Solara board as chairman
Robust demand for the product across the Middle East, Africa and Latin America
WHO prequalification enables the procurement of ROTAVAC 5D by UN agencies namely UNICEF and PAHO
It posted net profit of Rs.147.76 crores for the period ended June 30, 2020.
The company posted net profit of Rs.89.20 crores for the period ended June 30, 2020.
The company posted net profit of Rs.111.44 crores for the period ended June 30, 2020.
The company reported total income Rs.18.57 crores during the period ended June 30, 2020.
The Cephalosporin Injectables plant has a total capacity of 26.4 million vials per year while Ethiopia is having a demand for 16 million vials
Subscribe To Our Newsletter & Stay Updated
